Friday, March 06, 2015
Bayer HealthCare announced today that it has contributed one million dollars to the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) to support CancerLinQ™, a cutting edge health information technology platform designed to unlock vast quantities of information about the experiences of people living with cancer.
"Bayer is proud to join ASCO and the Conquer Cancer Foundation in their efforts to leverage Big Data to help people whose lives have been affected by cancer," said Svetlana Kobina, MD, PhD, Head of Global Medical Affairs, Oncology, Bayer HealthCare. "CancerLinQ is exciting in its potential to transform the future of cancer care through its ability to generate greater insights about patients living with cancer. This information can potentially help capture valuable data about quality of life during drug development."
The CancerLinQ system will provide insights needed to help increase understanding of the needs of cancer patients and their caregivers. The insights collected will ultimately contribute to high-quality, personalized cancer care for every patient.
"We are grateful for Bayer HealthCare's support of CancerLinQ, which aims to rapidly improve the overall quality of cancer care," said ASCO President Peter Paul Yu, MD, FACP, FASCO. "Instead of learning from only the three percent of cancer patients who participate in clinical trials, CancerLinQ will allow oncologists to learn from almost every patient."
For additional information about CancerLinQ, please visit http://CancerLinQ.org.
Bayer has a long-standing commitment to ASCO and the Conquer Cancer Foundation's mission of seeking advances in the prevention and treatment of cancer.
Source : http://www.cnbc.com/
